23 June 2020 : Clinical Research
The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis
Mei Tian1BE, Xiuchun Yang1CD, Yanfang Li1BF, Sen Guo2ABCDEFG*DOI: 10.12659/MSM.923359
Med Sci Monit 2020; 26:e923359
Figure 1 The expression of dynamin 1, 2, and 3 in tissue sections of hepatocellular carcinoma (HCC) and adjacent normal liver tissues using immunohistochemistry and quantitative real-time polymerase chain reaction (qRT-PCR). (A–C) The expression of dynamin 1, 2, and 3 detected with immunohistochemistry. Representative photomicrographs of the HCC tissue show positive immunostaining for dynamin. (D) The mRNA level of dynamin 1, 2, and 3, were detected by qRT-PCR in 14 paired tissue samples of HCC and normal adjacent liver tissue.